5项常规血液透析护理实用性随机试验中知情同意流程的调整
本文描述5项血液透析护理实用性随机试验中调整知情同意流程的经验,涉及透析液温度、镁、碳酸氢盐、溶质清除扩展和移植可及性。调整方式包括豁免同意、通知退出、临床记录偏好及选择性数据收集单独同意,在最小风险、常规书面同意不可行等条件下伦理可接受。
要点
- 调整知情同意可包括豁免、通知退出、临床记录偏好或选择性单独同意。
- 调整需满足最小增量风险、书面同意不可行、维护参与者福利等条件。
- 结合患者通知、退出机会和独立监督可使调整后的同意保持尊重透明。
核心结论
- 在满足最小增量风险、常规书面同意不可行等条件下,调整知情同意流程伦理可接受,并能支持原本难以开展的严谨试验。
研究设计与样本
- 描述5项血液透析护理干预的实用性随机试验的知情同意流程经验。
主要发现
- 5项试验分别涉及透析液温度、镁、碳酸氢盐、溶质清除扩展和移植可及性。
- 这些试验对试验参与、接受分配干预和常规收集数据的使用采用了不同的同意方式。
关键数值与推荐
- 调整知情同意可伦理接受需满足:研究风险不超过常规诊疗的最小增量风险、常规书面同意不可行或损害试验有效性、维护参与者福利、沟通适当。
- 调整方式包括:特定试验要素豁免同意、通知退出流程、临床记录偏好、选择性数据收集单独同意。
临床怎么用
- 设计试验时结合患者通知、退出机会、独立监督、关注脆弱性和包容性及可接受的干预实施,可使调整后的同意保持尊重透明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large, pragmatic, randomized trials are needed to identify which components of routine hemodialysis care improve outcomes, but conventional processes, including individual written consent for every eligible patient, can make some trials infeasible. Alterations to the consent process refer to departures from the usual written informed consent requirements: Consent may be waived for a specific trial element, the process may be modified through notification with an opt-out, preferences may be documented in usual clinical records, or separate consent may be used for selected data collection. These alterations may be ethically acceptable when the research poses no more than minimal incremental risk beyond usual care, usual written consent is impracticable or would compromise the validity of the trial, participant welfare is maintained, and communication with participants remains appropriate. We describe our experience with 5 pragmatic randomized trials of hemodialysis care interventions, including trials of dialysate temperature, magnesium, bicarbonate, expanded solute removal, and transplant access. These trials used different approaches to consent for trial participation, receipt of the allocated intervention, and use of routinely collected data. When designed with patient notification, opt-out opportunities, independent oversight, attention to vulnerability and inclusivity, and acceptable intervention delivery, alterations to the consent process can remain respectful, transparent, and attentive to patients' interests, while enabling rigorous trials that might otherwise not be conducted.
引用
- Garg AX, Al-Jaishi AA, Conklin AI, et al. Alterations to the Consent Process in 5 Pragmatic Randomized Trials of Routine Hemodialysis Care. J Am Soc Nephrol. 2026. PMID: 42623154. doi:10.1681/ASN.0000001251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。